Brachytherapy is a mature treatment modality that has benefited from technological
advances. Treatment planning has advanced from simple lookup tables to complex …

Significant advances have been made in the application of pharmacogenomic testing for the
treatment of patients with psychiatric disorders. Over the past decade, a number of studies …

The charge of Task Group 186 (TG‐186) is to provide guidance for early adopters of model‐
based dose calculation algorithms (MBDCAs) for brachytherapy (BT) dose calculations to …

This report addresses uncertainties pertaining to brachytherapy single‐source dosimetry
preceding clinical use. The International Organization for Standardization (ISO) Guide to the …

Dosimetry of eye plaques for ocular tumors presents unique challenges in brachytherapy.
The challenges in accurate dosimetry are in part related to the steep dose gradient in the …

The American Association of Physicists in Medicine (AAPM) formed Task Group 221 (TG‐
221) to discuss a generalized commissioning process, quality management considerations …

The surface brachytherapy Task Group report number 253 discusses the common treatment
modalities and applicators typically used to treat lesions on the body surface. Details of …

Although a multicenter, Phase III, prospective, randomized trial is the gold standard for
evidence‐based medicine, it is rarely used in the evaluation of innovative devices because …

The task group (TG) on magnetic resonance imaging (MRI) implementation in high‐dose‐
rate (HDR) brachytherapy (BT)—Considerations from simulation to treatment, TG 303, was …

The current standard for brachytherapy dose calculations is based on the AAPM TG‐43
formalism. Simplifications used in the TG‐43 formalism have been challenged by many …